Subsidies for Genetic Tests
This list comprises genetic tests assessed to be clinically and cost-effective. Individuals who have tested positive for a target gene referred through approved clinical pathways may be subsequently recommended for follow-up downstream interventions.
Last updated 1 April 2026
Genetic Test List (As of 1 April 2026)
Clinical indication | Target genes | Clinical criteria (population) | Additional criteria | Pre-subsidy prices[1] |
Familial Hypercholesterolaemia (FH) | Proband testing (gene panel)
LDLR, PCSK9, APOB | Individuals with low-density lipoprotein cholesterol (LDL-C) ≥ 5.5 mmol/L (≥ 212 mg/dL). | Individuals are eligible for subsidy once per lifetime. | $537 |
Cascade testing (variant-specific)
LDLR, PCSK9, APOB | First-degree[2] biological relatives of an individual who carries a pathogenic / likely pathogenic variant for Familial Hypercholesterolaemia. | Individuals are eligible for subsidy once per variant. | $107 |
[1] Additional services associated with genetic testing – such as phlebotomy, genetic counselling, and lab handling fees – are charged separately and not included in the prices shown.
[2] Refers to a parent, sibling, or child of a proband.